Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Before investing your money, it's essential to understand key factors. Get informed to make the best investment decisions.
21,805 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A Wayfair founder sold shares worth about $2.1 million in February 2026. This article breaks down what insider sellin...
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
A concentrated bet from a top consumer-focused fund puts Chime in the spotlight. Discover what the $227 million posit...
A new Colorado bill could tax income that doesn't really exist by altering how the AMT and net operating losses are t...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
This in-depth guide helps investors decode McDonald's 2026 earnings by examining the Q1 transcript, key drivers, and ...
Palantir stock is under pressure as AI enthusiasm wavers and growth expectations shift. This guide breaks down the re...
As market conditions evolve in 2026, DGRO’s dividend growth and low costs make a compelling case for holding DGRO in ...
Aurora Innovation saw a dramatic rally in the first half of 2026. This article explores the factors behind the move, ...